Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?

Detalles Bibliográficos
Autores principales: Ferrara, Francesco, Porta, Raffaele La, Santilli, Priscilla, D'Aiuto, Vilma, Vitiello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025773/
https://www.ncbi.nlm.nih.gov/pubmed/33283779
http://dx.doi.org/10.4103/ijp.IJP_417_20
_version_ 1783675554534260736
author Ferrara, Francesco
Porta, Raffaele La
Santilli, Priscilla
D'Aiuto, Vilma
Vitiello, Antonio
author_facet Ferrara, Francesco
Porta, Raffaele La
Santilli, Priscilla
D'Aiuto, Vilma
Vitiello, Antonio
author_sort Ferrara, Francesco
collection PubMed
description
format Online
Article
Text
id pubmed-8025773
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80257732021-04-08 Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times? Ferrara, Francesco Porta, Raffaele La Santilli, Priscilla D'Aiuto, Vilma Vitiello, Antonio Indian J Pharmacol Letter to the Editor Wolters Kluwer - Medknow 2020 2020-12-05 /pmc/articles/PMC8025773/ /pubmed/33283779 http://dx.doi.org/10.4103/ijp.IJP_417_20 Text en Copyright: © 2020 Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letter to the Editor
Ferrara, Francesco
Porta, Raffaele La
Santilli, Priscilla
D'Aiuto, Vilma
Vitiello, Antonio
Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
title Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
title_full Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
title_fullStr Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
title_full_unstemmed Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
title_short Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
title_sort are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025773/
https://www.ncbi.nlm.nih.gov/pubmed/33283779
http://dx.doi.org/10.4103/ijp.IJP_417_20
work_keys_str_mv AT ferrarafrancesco aremultiplesclerosistherapiessafeinsevereacuterespiratorysyndromecoronavirus2times
AT portaraffaelela aremultiplesclerosistherapiessafeinsevereacuterespiratorysyndromecoronavirus2times
AT santillipriscilla aremultiplesclerosistherapiessafeinsevereacuterespiratorysyndromecoronavirus2times
AT daiutovilma aremultiplesclerosistherapiessafeinsevereacuterespiratorysyndromecoronavirus2times
AT vitielloantonio aremultiplesclerosistherapiessafeinsevereacuterespiratorysyndromecoronavirus2times

Ejemplares similares